Learn more about the future direction of the Life Sciences industry in the U.S. by accessing key sessions from the 2012 LES (USA & Canada) Spring Meeting.

Learn more about the future direction of the Life Sciences industry in the U.S. by accessing these key sessions from the 2012 LES (USA & Canada) Spring Meeting:

Licensing as a Source of Innovation
Genzyme CEO David Meeker

Plenary Panel:  Licensing to Solve the Innovation Gap
Featuring:
Daniel Behr, Access BridgeGap Ventures
Jeff Elton, Accenture
Robert  Langer, MIT

These sessions are available to all LES members worldwide for the preferred rate of $159.00 for both sessions, or $100.00 for each session.

To purchase your session and download the content, visit: